In vitro Activity of Ceftobiprole and Comparator Agents Against Contemporary US Clinical Isolates Collected in 2025 Following FDA Approval (IDWeek 2026) - Sep 6, 2026 - Abstract #P - 142; Pres time: Oct 22, 2026; 12:15 PM - 01:30 PM; Location: Poster Hall B-C; No abstract available
Preclinical • Infectious Disease
|
|
Rodrigo E. Mendes, PhD (he/him/his); Marisa Winkler, MD, PhD; Samir H. Moussa, PhD; Tatiana Wiktorowicz; Helio Sader; Mariana Castanheira, PhD
|